ConductScience.org, home

Trial · NCT07901621

Registered outcomes25

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
SecondaryFat MassWeek 0 (baseline) and week 13 (post-intervention)Whole-body fat mass assessed by DXA, in kg.
SecondaryBody Fat PercentageWeek 0 (baseline) and week 13 (post-intervention)Whole-body fat percentage assessed by DXA, in %.
SecondaryBone Mineral DensityWeek 0 (baseline) and week 13 (post-intervention)BMD (g/cm2) at the lumbar spine (L1-L4), femoral neck, and one-third (33%) radius of the non-dominant forearm, by DXA.
SecondaryTraining AdherenceDuring the 12-week interventionPercentage of the 36 prescribed sessions attended (CT and MCT groups).
SecondaryAdverse EventsDuring the 12-week interventionNumber and proportion of participants with adverse events, classified by severity, relationship to the intervention, and expectedness (CONSORT Harms 2022).

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07901621/registered?page=2